It is likely that the observed differences in the effects of IRP2 on the cell cycle in these two cell lines is a result of differences in their genetic backgrounds, since LNCaP and PC3 cells derive from quite different prostate tumors [30–32]. The gene discussed is IREB2; the disease is prostate neoplasm.